Teriflunomide (previously A77 1726) is the active metabolite of leflunomide. Like leflunomide, it is used for rheumatoid arthritis. , teriflunomide is investigated in the Phase III clinical trial TEMSO as a medication for multiple sclerosis (MS). The study is expected to run until October 2010.
Adapted from the Wikipedia article Teriflunomide, under the G. N. U. Free Documentation License. Please also see http://en.wikipedia.org/wiki
Teriflunomide – Introduction
Teriflunomide (previously A77 1726) is the active metabolite of leflunomide. Like leflunomide, it is used for rheumatoid arthritis. , teriflunomide is investigated in the Phase III clinical trial TEMSO as a medication for multiple sclerosis (MS).
If you enjoyed this article, please consider sharing it!
Related Videos
CreakyJoints -- creakyjoints.org -- was proud to help sponsor a video series examining ways to improve one's life despite a diagnosis of rheumatoid arthritis (RA)....
rheumatoidarthritissymptomstest.com - Rheumatoid Arthritis Symptoms, what can you learn about this condition....
Rheumatoid arthritis affects 1.3 million Americans. Research advances and drug development have helped control this chronic disease. Noted UCLA Rheumatology expert Dr. Michael Weisman, presents...